Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An X-linked retinopathy caused by variants in the NYX gene.
Biomarker and diagnostic research for NYX-related retinopathy has been reported in the published literature.
No clinical trials have been registered for NYX-related retinopathy.
5 publications have been identified in PubMed for NYX-related retinopathy. Research spans Diagnostic / Biomarker (20%), Review / Meta-Analysis (20%), and Basic Science / Preclinical (20%).
Han C (2026). [PMID: 41742148](https://pubmed.ncbi.nlm.nih.gov/41742148/). *BMC Med Genomics*. [Gene Therapy / Novel Therapeutics]
Zaslavsky K (2025). [PMID: 41342616](https://pubmed.ncbi.nlm.nih.gov/41342616/). *Invest Ophthalmol Vis Sci*. [Epidemiology / Natural History]
Durajczyk M (2025). [PMID: 40004769](https://pubmed.ncbi.nlm.nih.gov/40004769/). *J Clin Med*. [Review / Meta-Analysis]
Ovens CA (2025). [PMID: 40439747](https://pubmed.ncbi.nlm.nih.gov/40439747/). *Graefes Arch Clin Exp Ophthalmol*. [Basic Science / Preclinical]
Xu Z (2024). [PMID: 39530998](https://pubmed.ncbi.nlm.nih.gov/39530998/). *Invest Ophthalmol Vis Sci*. [Diagnostic / Biomarker]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 3:08 PM UTC
Common questions about NYX-related retinopathy